Last news
Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as

...

VCI Global Announces 1-for-49 Reverse Stock Split

VCI Global Announces 1-for-49 Reverse Stock Split

...

Founder Group Limited Announces USD$3.8 million New Solar EPCC Photovoltaic Contract

Founder Group Limited Announces USD$3.8 million New Solar EPCC Photovoltaic Contract

...

Bitget's Survey Reveals Some Users Prefer Influencer Videos Over Whitepapers to Make Trading Choices

Bitget's Survey Reveals Some Users Prefer Influencer Videos Over Whitepapers to Make Trading Choices

...

SiriusPoint reports eighth consecutive quarter of underwriting profits and seventh consecutive quarter of positive net income

SiriusPoint reports eighth consecutive quarter of underwriting profits and seventh consecutive quarter of positive net income

...

Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak

Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak

...

NUAIR and SRAA Celebrate New Headquarters and Highlight Central New York’s Leadership in Advanced Air Mobility and Drone Innovation

NUAIR and SRAA Celebrate New Headquarters and Highlight Central New York’s Leadership in Advanced Air Mobility and Drone Innovation

...

Meltwater and Cyabra Partner to Address Dis- and Misinformation Threats to Brands

Meltwater and Cyabra Partner to Address Dis- and Misinformation Threats to Brands

...

1 ... 313 314 315 316 317 318 319 320 321 ... 970
menu
menu